Mahchid Bamdad
5PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 29, 2025
LightSpot Fluorescent Conjugates as Highly Efficient Tools for Lysosomal P-gp Quantification in Olaparib-Treated Triple-Negative Breast Cancer Cells.Antoine Goisnard, Pierre Daumar, Maxime Dubois
|Aug 27, 2021
LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.Antoine Goisnard, Pierre Daumar, Clémence Dubois
|Apr 30, 2021
The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.Antoine Goisnard, Clémence Dubois, Pierre Daumar
|Apr 15, 2020
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells.Abderrahim El Guerrab, Mahchid Bamdad, Yves-Jean Bignon
|Jan 01, 2020
Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.Clémence Dubois, Fanny Martin, Chervin Hassel
Pageof 1
